| Literature DB >> 29720133 |
Douglas Archibald1,2, Julia Stratton3, Clare Liddy4,5, Rachel E Grant6, Douglas Green3, Erin J Keely7,8.
Abstract
BACKGROUND: This study explores the effectiveness of an electronic consultation (eConsult) service between primary care providers and psychiatry, and the types and content of the clinical questions that were asked.Entities:
Keywords: Electronic consultation; Primary health care; Psychiatry; eConsult
Mesh:
Year: 2018 PMID: 29720133 PMCID: PMC5932827 DOI: 10.1186/s12888-018-1701-3
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Content of close-out survey for primary care providers
| Question | Response Options |
|---|---|
| Q1. Which of the following best describes the outcome of this eConsultation for your patient: | 1. I was able to confirm a course of action that I originally had in mind; |
| Q2. As a result of the eConsultation would you say that: | 1. Referral was originally contemplated but now avoided at this stage; |
| Q3. Please rate the overall value of the eConsult. | Minimal 1 2 3 4 5 Excellent |
| Q4. Please rate the overall value of the eConsult service in this case for you as a primary care providers. | Minimal 1 2 3 4 5 Excellent |
| Q5. We would value any additional feedback you provide: |
List of content topics in electronic consultation
| Content Topic | No. eConsults | % eConsults |
|---|---|---|
| Depressive Disorders | 51 | 30.2% |
| Anxiety Disorders | 28 | 16.6% |
| Neurodevelopmental Disorders | 21 | 12.4% |
| Bipolar and Related Disorders | 20 | 11.8% |
| Schizophrenia Spectrum and Other Psychotic Disorders | 18 | 10.7% |
| Personality Disorders | 5 | 3.0% |
| Substance-Related and Addictive Disorders | 5 | 3.0% |
| Obsessive-Compulsive and Related Disorders | 4 | 2.4% |
| Disruptive, Impulse-Control, and Conduct Disorders | 3 | 1.8% |
| Medication-Induced Movement Disorders and Other Adverse Effects of Medication | 3 | 1.8% |
| Neurocognitive Disorders | 3 | 1.8% |
| Sleep-Wake Disorders | 3 | 1.8% |
| Somatic Symptom and Related Disorders | 2 | 1.2% |
| Feeding and Eating Disorders | 1 | 0.6% |
| Trauma- and Stressor-Related Disorders | 1 | 0.6% |
| Unable to classify | 1 | 0.6% |
Classification of question type
| Question Type | No. eConsults | % eConsults |
|---|---|---|
| Drug Treatment | ||
| Drug of choice | 66 | 39.1% |
| Adverse effects of drugs | 27 | 16.0% |
| Other | 15 | 8.9% |
| How to prescribe a particular drug | 10 | 5.9% |
| Interactions between drugs | 6 | 3.6% |
| Indications / goals of treating a particular condition | 4 | 2.4% |
| Drug treatment total | 128 | 75.7% |
| Clinical Management | ||
| General management question | 17 | 10.1% |
| Other providers available | 6 | 3.6% |
| Clinical management total | 23 | 13.6% |
| Diagnosis | ||
| Interpretation of a clinical finding | 11 | 6.6% |
| Other | 3 | 1.8% |
| What test to choose | 2 | 1.2% |
| Interpretation of a laboratory test | 1 | 0.6% |
| Diagnosis total | 17 | 10.1% |
| No specific question | 1 | 0.6% |
Responses to close-out survey question 2: As a result of the eConsultation would you say that…
| Response | No. eConsults | % eConsults |
|---|---|---|
| 1. Referral was originally contemplated but now avoided at this stage; | 52 | 30.8% |
| 2. Referral was originally contemplated and is still needed – this eConsult likely leads to a more effective visit; | 47 | 27.8% |
| 3. Referral was not originally contemplated and is still not needed – this eConsult provided useful feedback/instruction; | 60 | 35.5% |
| 4. Referral was not originally contemplated, but eConsult process resulted in a referral being initiated; | 2 | 1.2% |
| 5. There was no particular benefit to using eConsult in this case; | 5 | 3.0% |
| 6. Other (please explain). | 3 | 1.8% |
Psychiatry content taxonomy for classifying eConsults
| Anxiety Disorders | |
| Bipolar and Related Disorders | |
| Depressive Disorders | |
| Dissociative Disorders | |
| Disruptive, Impulse-Control, and Conduct Disorders | |
| Elimination Disorders | |
| Feeding and Eating Disorders | |
| Gender Dysphoria | |
| Medication-Induced Movement Disorders and Other Adverse Effects of Medication | |
| Neurocognitive Disorders | |
| Neurodevelopmental Disorders | |
| Obsessive-Compulsive and Related Disorders | |
| Paraphilic Disorders | |
| Personality Disorders | |
| Schizophrenia Spectrum and Other Psychotic Disorders | |
| Sexual Dysfunctions | |
| Sleep-Wake Disorders | |
| Substance-Related and Addictive Disorders | |
| Trauma-and Stressor-Related Disorders |
Examples of eConsult clinical questions
| Depression | |
| 35 year old woman with dysthymia. Has been seeing a psychologist for over a year. Symptoms of low mood, decreased motivation and anhedonia. Not suicidal. No alcohol or drug use. No significant anxiety symptoms. Was started on Prozac and dose increased up to 40 mg without effect. She was then switched to Effexor with dose titrated up to 225 mg with little response. Do you have any suggestions? | |
| ADHD | |
| 21 year old university student with diagnosis of ADD. Treated with Concerta 54 mg in the morning and Ritalin 30 mg at lunch/early afternoon as he has an evening class. He has asked to increase the dose of Concerta but I am uncomfortable with that as the dose is already high. Otherwise healthy. Takes no other medications. What would you advise? | |
| Anxiety/Insomnia | |
| My question is about insomnia. 42 year old woman is severely anxious and reports episodes of panic attacks. She is currently on sertraline 50 mg which is being titrated up but still has primary and secondary insomnia. She has responded to zopiclone 3.25 mg prn for small periods of time but I do not want to continue this due to the risk of tolerance/dependence. She is unable to tolerate trazodone. Is it reasonable to use zopiclone long term? Otherwise would nortriptyline be safe to use with sertraline? If so at what dose? Do you have other suggestions? |